Recent studies suggest that BCAAs are not just associated with obesity and T2D, two strong risk factors for AD, but they also are capable of impairing glycemic control and insulin sensitivity [9,10,11,12,13,14,15]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.